Table 1.
Pharmacologic Agents | No. of Patients | VF | VT, (sustained VT) | Bradycardia | Shock | Tamponade | AMI | DC | CABG | Death | Serious Major Complications, n (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Buxton (1980) | ER IV | 106 | 2 | 1 (1) | 2 | 5 | 0 | 0 | 0 | 1 | 3 | 5 (4.72) |
Bertrand (1982) | Methyl ER IV | 1089 | 4 | 1 (1) | 2 | — | 0 | 0 | 4 | 0 | 0 | 5 (0.46) |
Harding (1992) | ER IV | 3447 | (7) | (7) | — | — | — | 4 | — | 0 | 0 | 11 (0.03) |
Ong (2014) | ACh IC | 847 | 0 | 1 (0) | 6 | — | 0 | 0 | 0 | 0 | 0 | 0 (0) |
Sueda (1999) | ACh IC | 715 | 0 | 7 (1) | — | 2 | 1 | 0 | 1 | 0 | 0 | 4 (0.56) |
Abbreviations: ACh, acetylcholine; AMI, acute myocardial infarction; CABG, coronary artery bypass graft; DC, direct current; ER, ergonovine; IC, intracoronary; IV, intravenous; VF, ventricular fibrillation; VT, ventricular tachycardia.